L000 Stock Chart & Stats
€0.01
-€0.04(-79.25%)
At close: 4:00 PM EDT
€0.01
-€0.04(-79.25%)
Day’s Range― - ―
52-Week Range€0.02 - €0.51
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
€35.56K
Enterprise Value€3.06
Total Cash (Recent Filing)€43.85K
Total Debt (Recent Filing)€2.78M
Price to Earnings (P/E)―
Beta-40.11
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding1,043,568
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.02
Price to Sales (P/S)1.97
P/FCF Ratio-0.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Losses Have ModeratedLower losses than in 2021 may indicate some reduction in the scale of deterioration. However, this is only a relative improvement because revenue is shrinking, gross profit remains negative, and the company is still materially unprofitable.
Reduced Operating Cash OutflowThe moderation in operating cash outflow could provide some additional runway compared with prior periods. It does not yet establish financial self-sufficiency, since operating and free cash flow remain negative and external funding is still required.
Historically Modest Debt BaseA historically modest debt burden may have limited prior interest and repayment pressure. This offers some context for financial flexibility, although the benefit is weakening as debt has risen to approximately 2.8M TTM alongside negative equity.
Bears Say
Shrinking RevenuePersistent revenue contraction signals weakening demand, distribution, or product traction and reduces the scale available to absorb fixed costs. Continued declines would make a return to sustainable profitability more difficult over the next several months.
Negative Gross Profit And Severe LossesCosts exceeding sales at the gross-profit level indicate that the current operating model is not covering direct costs. Persistent operating losses and a deeply negative net margin create a fundamental need for cost restructuring, pricing improvement, or new funding.
Solvency And Cash Burn RiskNegative equity limits balance-sheet resilience and access to conventional financing, while rising debt increases obligations. Ongoing operating and free-cash-flow burn means the company has not demonstrated the ability to fund operations internally.
L000 FAQ
What was Global Health Clinics’s price range in the past 12 months?
Global Health Clinics lowest stock price was €0.02 and its highest was €0.51 in the past 12 months.
What is Global Health Clinics’s market cap?
Global Health Clinics’s market cap is €35.56K.
When is Global Health Clinics’s upcoming earnings report date?
Global Health Clinics’s upcoming earnings report date is Dec 01, 2026 which is in 95 days.
How were Global Health Clinics’s earnings last quarter?
Currently, no data Available
Is Global Health Clinics overvalued?
According to Wall Street analysts Global Health Clinics’s price is currently Overvalued.
Does Global Health Clinics pay dividends?
Global Health Clinics does not currently pay dividends.
What is Global Health Clinics’s EPS estimate?
Global Health Clinics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Health Clinics have?
Global Health Clinics has 1,043,568 shares outstanding.
What happened to Global Health Clinics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Global Health Clinics?
Currently, no hedge funds are holding shares in DE:L000
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Global Health Clinics
Operating within the cannabis industry, Global Health Clinics Ltd. manages medical facilities that provide guidance to patients seeking to legally obtain and use marijuana. The company is also involved in creating psilocybin products designated for scientific research and pharmaceutical development. It was formerly known as Leo Resources Inc., changing its name to Global Health Clinics Ltd. in August 2018. Established in 2013, its primary operations are based in Vancouver, Canada.